Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

15:50 09/01/2026

Wanbangde (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd. ("Wanbangde Pharmaceutical"), has been selected for the Alzheimer's disease project under the national major special project for innovative drug development led by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company has received the approval from the National Health Commission of China's Center for Biotechnology Development.

Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Holding Group Pharmaceutical Group Co., Ltd. ("Wanbangde Pharmaceutical Holding Group Pharmaceutical"), has been selected for the Alzheimer's disease project under the National Science and Technology Major Project for Innovative Drug Development led by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company has received approval from the National Health Commission's China Center for Biotechnology Development.

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

US Stock Market Move | Atlas Critical Minerals (ATCX.US) transferred to the Nasdaq, opening stock price dropped more than 35%.

US Stock Market Move | Rare earth concept continues to rise, Critical Metals (CRML.US) surges over 17%

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

US Stock Market Move | Atlas Critical Minerals (ATCX.US) transferred to the Nasdaq, opening stock price dropped more than 35%.

US Stock Market Move | Rare earth concept continues to rise, Critical Metals (CRML.US) surges over 17%